Press Releases

SANTA FE, N.M., Feb. 25, 2020 /PRNewswire/ -- Nature's Toolbox, Inc. (NTx), an early stage biomanufacturing and bioinformatics company, today announced that it has raised $13 million in new funding. The Series A round was led by venture capital firm Anzu Partners. The new funding will be used to advance the company's proprietary host-i

NEW YORK, Feb. 25, 2020 /PRNewswire/ -- One Drop, a leader in digital therapeutics solutions for people living with diabetes and other chronic conditions, presented new results for continuous glucose monitor-based glucose predictions at

PARIS, Feb. 25, 2020 /PRNewswire/ -- Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and

BOSTON, Feb. 25, 2020 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced Seven Bridges ARIA™, the first cloud-based solution aimed at improving and accelerating the discovery of meaningful connections between genomics, health data and biological knowledge at the 1M+ participant scale. By connecting genetics and h

CRANFORD, N.J., Feb. 25, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today cited independent research on the incidence of catheter-related blood stream infections (CRBSIs) in the world.DelveInsight had previo

NETANYA, Israel, and NEW YORK, Feb. 25, 2020 /PRNewswire/ -- Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain conditions, and

SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the fourth quarter and full year-ended December 31, 2019."In 2019, we advanced MRTX849, our KRAS G12C inhibitor into a Phase 1/2 clinical trial, showing initial promi

LOVELAND, Colo., Feb. 25, 2020 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) ("Heska" or "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its fourth quarter and full year ended December 31, 2019. The Company reports results in two segments: Core Companion Animal ("CCA")

DUBLIN, Ohio, Feb. 25, 2020 /PRNewswire/ -- Athletic Republic, the leading sports performance training franchise, is opening a new center in Dublin, Ohio in early May of 2020. Local athletes of all ages will now have access to science-based training methods proven to increase speed, power, agility, and stamina.

SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- 'Lutetium-177 (Lu-177) market and Pipeline Analysis - Forecast to 2026' gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET, Prostate cancer and other diseases. The repor